ZNF280A通过调节细胞增殖,细胞亡和细胞周期来促进恶性黑色素瘤的发展
Wenjun Zheng1, Zhuren Ruan1, Yuanyuan Chen1
1Department of Dermatology and Venerology, the First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong RD, Nanning, 530021, China.
Discover oncology
|April 18, 2025
概括
指蛋白ZNF280A是恶性黑色素瘤 (MM) 发展的危险因素. 降低ZNF280A抑制了MM细胞的生长,迁移和入侵,影响了预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 恶性黑色素瘤 (MM) 是一种致命的皮肤癌,每年有超过30万例.
- 了解MM开发机制仍然不完整.
- 指蛋白在MM中的作用在很大程度上是未被探索的.
研究的目的:
- 为了确定恶性黑色素瘤中的新型分子驱动因素.
- 调查指蛋白ZNF280A在MM病变发生过程中的作用.
- 探索ZNF280A作为MM的潜在预后因素.
主要方法:
- 在MM组织中对ZNF280A表达的定量分析与相邻的正常组织相比.
- 在体外和体内实验涉及ZNF280A在MM细胞中的敲除.
- 细胞增殖,迁移,入侵,细胞循环和细胞亡的评估.
- 与ZNF280A水平相关的p53表达的分析.
主要成果:
- 相比之下,ZNF280A的表达在MM组织中显著升高,而不是帕拉癌组织.
- 镇压ZNF280A抑制了MM细胞的增殖,迁移和入侵.
- 降低ZNF280A水平导致细胞亡和细胞循环停止的增加.
- 这些效应似乎通过调节p53表达来调节.
结论:
- ZNF280A被确定为恶性黑色素瘤的新型风险因素和驱动因素.
- ZNF280A通过影响细胞增殖,迁移,入侵,细胞周期和细胞亡来促进MM的发展.
- 向ZNF280A可能为MM提供一种潜在的治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
The Intrinsic Apoptotic Pathway
5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K


